ARCHIVES

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

This article is from The Cancer Letter archive.

Vol. 33 No. 14 | April 13, 2007

Download PDF Visit The Full Archive

Related Articles

CPT-11, Gemcitabine Increase Survival Of Pancreatic Cancer

March 29, 2002

In Brief: Gallo Lists Followup Projects For Human Cancer Virus; Zubrod Responds To Cancer Program Critics

April 11, 1975

House Passes Cancer Act Renewal With Provision Permitting NCI To Reinstate Training Program

May 10, 1974

NCCN Admits Two New Member Institutions

March 22, 2013

DCE Concepts Approved

June 27, 1986

The March Attracts Thousands To Rally For Research Funding, Access To Care

October 2, 1998